This observation is consistent with our hypothesis that the TP53 biomarker measures the effect of hereditary susceptibility to lung cancer and, therefore, is independent and synergistic with risk conferred by cigarette smoke exposure. The gene discussed is TP53; the disease is lung carcinoma.